Palvella Therapeutics PVLA
NASDAQ PVLA
$165.47 -8.61 (-4.95%)
As of: Nov 10, 2026 · 2:57 PM EST

Palvella Therapeutics (PVLA) Net Long-Term Debt Issued (Repaid) (2015 - 2024)

Updated

Palvella Therapeutics' Non-Current Debt was $1.36 million in FY2014.

Analysis

Palvella Therapeutics (PVLA) Net Long-Term Debt Issued (Repaid) (2015 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Palvella Therapeutics 2.38 Bn 2.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6.00 Mn
Sep 30, 2024 2.43 Mn
Sep 30, 2015 13,230.00
Jun 30, 2015 -43,365.00
Mar 31, 2015 -1.13 Mn
API Access

Palvella Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PVLA&period=max&api_key=YOUR_API_KEY